Table 1 Characteristics of the study population
Characteristic | N = 229 |
|---|---|
Age (years), median (IQR) | 60 (55–66) |
Female sex, n (%) | 146 (63.7) |
Current smoker, n (%) | 12 (5.2) |
Former smoker, n (%) | 82 (35.8) |
Never smoked | 135 (59) |
Duration of diabetes (years), median (IQR) | 1.0 (0.3–2.3) |
Family history of diabetes, n (%) | 78 (34.1) |
No Claudication, n (%) | 126 (55.0) |
Atypical Claudication, n (%) | 54 (23.6) |
Definite Claudication, n (%) | 49 (21.4) |
Self-reported hypertension, n (%) | 113 (49.3) |
HIV infection, n (%) | 18 (7.9) |
Diabetes treatmentπ, n (%) |  |
  Metformin only | 112 (51.6) |
  Glibenclamide only | 2 (0.9) |
  Glibenclamide and Metformin | 34 (15.7) |
  Insulin only | 52 (24) |
  Insulin and Metformin | 15 (6.9) |
Aspirin, n (%) | 17 (7.4) |
BMI (kg/m2), median (IQR) | 26.3 (22.6–29.4) |
Waist-to-hip ratio, median (IQR) | 1 (1–1) |
Systolic blood pressure (mmHg), median (IQR) | 140 (124–160) |
Diastolic blood pressure (mmHg), median (IQR) | 80 (70–90) |
Fasting blood sugar (mmol/L), median (IQR) | 8.6 (6.6–13.7) |
HbA1c (%), median (IQR) | 8.1 (6.7–10.1) |
HDL£-Cholesterol (mg/dL), median (IQR) | 48 (39–58) |
LDL¥-Cholesterol (mg/dL), median (IQR) | 81 (63–96) |
Triglycerides (mg/dL), median (IQR) | 116 (83–179) |
Total cholesterol (mg/dL), median (IQR) | 268 (212–307) |